Vulvovaginal skin conditions, namely vaginal atrophy, lichen sclerosus, lichen simplex chronicus and lichen planus affecting the female adult population will be treated with a novel gel dressing to test the short- and long-term safety and efficacy of the device.
Diagnosed atrophic vaginitis, lichen sclerosus, lichen simplex chronicus or lichen planus
Continuous vulvovaginal symptoms
Access to smartphone and tablet, laptop or computer
Access to a valid email address
Unable to provide informed consent
Patient unable to apply topical device
Allergy or intolerance to ingredients or excipients of the formulation of studied products
Systemic hormonal therapy started less than 30 days before baseline
Stratpharma AG
Lead sponsor